Procter & Gamble Co. is taking a sharp turn from trimming its product portfolio and streamlining its operations with an agreement to acquire Merck KGAA's dietary supplement and OTC drug lines, a move that will increase the size of P&G's consumer health business by 50%.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?